Cargando…

Practical use of sevelamer in chronic kidney disease patients on dialysis in People’s Republic of China

Hyperphosphatemia is a common complication of dialysis patients. Only 38.5% of Chinese dialysis patients met the Kidney Disease Outcomes Quality Initiative defined targets for serum phosphate. Sevelamer is a high molecular weight cationic hydrogel polymer that prevents absorption of dietary phosphat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meng, Lin, Fu, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425324/ https://www.ncbi.nlm.nih.gov/pubmed/25995642 http://dx.doi.org/10.2147/TCRM.S64657

Ejemplares similares

Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease–mineral bone disorder parameters in dialysis patients
por: Ketteler, Markus, et al.
Publicado: (2019)

A randomized, crossover design study of sevelamer carbonate powder and sevelamer hydrochloride tablets in chronic kidney disease patients on haemodialysis
por: Fan, Stanley, et al.
Publicado: (2009)

Sevelamer carbonate in the treatment of hyperphosphatemia in patients with chronic kidney disease on hemodialysis
por: Savica, Vincenzo, et al.
Publicado: (2008)

Incremental cost-utility of sevelamer relative to calcium carbonate for treatment of hyperphosphatemia among pre-dialysis chronic kidney disease patients
por: Nguyen, Hai V., et al.
Publicado: (2016)

Sevelamer carbonate increases serum bicarbonate in pediatric dialysis patients
por: Gonzalez, Elsa, et al.
Publicado: (2010)

Protein-Bound Uremic Toxins Lowering Effect of Sevelamer in Pre-Dialysis Chronic Kidney Disease Patients with Hyperphosphatemia: A Randomized Controlled Trial
por: Takkavatakarn, Kullaya, et al.
Publicado: (2021)

Epidemiology of chronic kidney diseases in the Republic of Guinea; future dialysis needs
por: Bah, Alpha Oumar, et al.
Publicado: (2015)

Effect of Sevelamer on Calciprotein Particles in Hemodialysis Patients: The Sevelamer Versus Calcium to Reduce Fetuin-A-Containing Calciprotein Particles in Dialysis (SCaRF) Randomized Controlled Trial
por: Smith, Edward R., et al.
Publicado: (2020)

Effect of Sevelamer and Nicotinamide on Albumin Carbamylation in Patients with End-Stage Kidney Disease
por: Lenglet, Aurelie, et al.
Publicado: (2021)

Different Effect of Lanthanum Carbonate and Sevelamer Hydrochloride on Calcium Balance in Patients with Moderate to Advanced Chronic Kidney Disease
por: Makowka, Agnieszka, et al.
Publicado: (2021)

Effects of sevelamer carbonate versus calcium acetate on vascular calcification, inflammation, and endothelial dysfunction in chronic kidney disease
por: Mason, Darius L., et al.
Publicado: (2021)

Efficacy of Lanthanum Carbonate and Sevelamer Carbonate as Phosphate Binders in Chronic Kidney Disease—A Comparative Clinical Study
por: Nain, Parminder, et al.
Publicado: (2023)

Sevelamer revisited: pleiotropic effects on endothelial and cardiovascular risk factors in chronic kidney disease and end-stage renal disease
por: Rastogi, Anjay
Publicado: (2013)

Long-Term Effects of Sevelamer on Vascular Calcification, Arterial Stiffness, and Calcification Propensity in Patients Receiving Peritoneal Dialysis: The Randomized Pilot SERENE (Sevelamer on Vascular Calcification, Arterial Stiffness) Trial
por: Wang, Angela Yee-Moon, et al.
Publicado: (2021)

Sevelamer Attenuates Bioprosthetic Heart Valve Calcification
por: Meng, Zhen, et al.
Publicado: (2021)

Update and critical appraisal of sevelamer in the management of chronic renal failure
por: Grinfeld, Jacob, et al.
Publicado: (2010)

Ischemic Colitis in Association with Sevelamer Crystals
por: Keri, K. C., et al.
Publicado: (2019)

Gastrointestinal complications induced by sevelamer crystals
por: Yuste, Claudia, et al.
Publicado: (2017)

Sevelamer Carbonate Crystal-Induced Colitis
por: Lai, T., et al.
Publicado: (2020)

Efficacy and Safety of Sevelamer Carbonate in Chinese Nondialysis Chronic Kidney Disease Patients with Hyperphosphatemia: A Randomized, Double-Blind, Parallel-Group Study
por: Chen, Wei, et al.
Publicado: (2022)

Sevelamer-Induced Gastrointestinal Injury Presenting as Gastroenteritis
por: Magee, Jared, et al.
Publicado: (2018)

Binding interactions with sevelamer and polystyrene sulfonate in vitro
por: van Berlo‐van de Laar, Inge R.F., et al.
Publicado: (2021)

Development and Validation of a Gas Chromatography Method for the Trace Level Determination of Allylamine in Sevelamer Hydrochloride and Sevelamer Carbonate Drug Substances
por: Kadiyala, Raju V. S. N., et al.
Publicado: (2014)

Insufficient Knowledge and Vaccination Practice of Inflammatory Bowel Disease Patients in the People's Republic of China
por: Feng, Shuyi, et al.
Publicado: (2020)

Expert consensus on acute exacerbation of chronic obstructive pulmonary disease in the People’s Republic of China
por: Cai, Bai-qiang, et al.
Publicado: (2014)

Plasma p-Cresol Lowering Effect of Sevelamer in Peritoneal Dialysis Patients: Evidence from a Cross-Sectional Observational Study
por: Guida, Bruna, et al.
Publicado: (2013)

Sevelamer carbonate experience in Indian end stage renal disease patients
por: Abraham, G., et al.
Publicado: (2012)

Sevelamer-Associated Rectosigmoid Ulcers in an End-Stage Renal Disease Patient
por: Uy, Pearl Princess, et al.
Publicado: (2018)

A randomized, double-blind, placebo-controlled, dose-ranging study using Genz-644470 and sevelamer carbonate in hyperphosphatemic chronic kidney disease patients on hemodialysis
por: Moustafa, Moustafa, et al.
Publicado: (2014)

Endotoxin Binding by Sevelamer: Potential Impact on Nutritional Status
por: Kubotera, Natsuki, et al.
Publicado: (2013)

Colonic Mass Secondary to Sevelamer-Associated Mucosal Injury
por: Bansal, Vishant, et al.
Publicado: (2017)

Sevelamer crystals—an unusual cause of large bowel obstruction
por: Cockrell, Hannah C, et al.
Publicado: (2021)

Short-term effects of sevelamer-carbonate on fibroblast growth factor 23 and pulse wave velocity in patients with normophosphataemic chronic kidney disease Stage 3
por: Bouma-de Krijger, Annet, et al.
Publicado: (2019)

Clinical and economic aspects of sevelamer therapy in end-stage renal disease patients
por: Ossareh, Shahrzad
Publicado: (2014)

The effect of sevelamer carbonate and lanthanum carbonate on the pharmacokinetics of oral calcitriol
por: Pierce, David, et al.
Publicado: (2011)

A case report of sevelamer-associated recto-sigmoid ulcers
por: Tieu, Christina, et al.
Publicado: (2016)

Comparison of Sevelamer and Calcium Carbonate in Prevention of Hypomagnesemia in Hemodialysis Patients
por: Jandaghi, Elahe, et al.
Publicado: (2021)

Investigation of Pneumocystis jirovecii colonization in patients with chronic pulmonary diseases in the People’s Republic of China
por: Wang, Dong-Dong, et al.
Publicado: (2015)

Cost Effectiveness of Sucroferric Oxyhydroxide Compared with Sevelamer Carbonate in the Treatment of Hyperphosphataemia in Patients Receiving Dialysis, from the Perspective of the National Health Service in Scotland
por: Gutzwiller, Florian S., et al.
Publicado: (2015)

Human Bocavirus Infection, People’s Republic of China
por: Qu, Xiao-Wang, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_i8cgpb873itcj8gheh4hvgffg5